{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["12"],"submitter":["Zhu Q"],"pubmed_abstract":["<h4>Purpose</h4>We aimed to investigate the restoration of CD8<sup>+</sup>PD-1<sup>+</sup> T cells through adoptive T-cell therapy (ACT) in relation to the prognosis and the therapeutic response to anti-PD-1 in patients with advanced pancreatic cancer (APC).<h4>Methods</h4>A total of 177 adult patients who underwent tumor resection as initial treatment for pancreatic ductal adenocarcinoma (PDAC) from February 2013 to July 2019 at Zhongnan Hospital of Wuhan University were enrolled in this study. Another cohort of 32 patients with APC was prospectively enrolled from Capital Medical University Cancer Center between June 1, 2013, and May 30, 2019.<h4>Results</h4>Of the 177 patients who received tumor resection, 67 tumor samples showed overexpression of PD-L1 and 110 patients with low expressi"],"journal":["Frontiers in oncology"],"pagination":["837560"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9035626"],"repository":["biostudies-literature"],"pubmed_title":["Restored CD8<sup>+</sup>PD-1<sup>+</sup> T Cells Facilitate the Response to Anti-PD-1 for Patients With Pancreatic Ductal Adenocarcinoma."],"pmcid":["PMC9035626"],"pubmed_authors":["Qiao G","Yang Z","Chen Z","Wang S","Xu C","Guo D","Liu B","Huang L","Zhu Q","Zhao J","Song Y","Yuan Y"],"additional_accession":[]},"is_claimable":false,"name":"Restored CD8<sup>+</sup>PD-1<sup>+</sup> T Cells Facilitate the Response to Anti-PD-1 for Patients With Pancreatic Ductal Adenocarcinoma.","description":"<h4>Purpose</h4>We aimed to investigate the restoration of CD8<sup>+</sup>PD-1<sup>+</sup> T cells through adoptive T-cell therapy (ACT) in relation to the prognosis and the therapeutic response to anti-PD-1 in patients with advanced pancreatic cancer (APC).<h4>Methods</h4>A total of 177 adult patients who underwent tumor resection as initial treatment for pancreatic ductal adenocarcinoma (PDAC) from February 2013 to July 2019 at Zhongnan Hospital of Wuhan University were enrolled in this study. Another cohort of 32 patients with APC was prospectively enrolled from Capital Medical University Cancer Center between June 1, 2013, and May 30, 2019.<h4>Results</h4>Of the 177 patients who received tumor resection, 67 tumor samples showed overexpression of PD-L1 and 110 patients with low expressi","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022","modification":"2025-04-19T13:00:54.556Z","creation":"2025-04-19T13:00:54.556Z"},"accession":"S-EPMC9035626","cross_references":{"pubmed":["35480107"],"doi":["10.3389/fonc.2022.837560"]}}